Growth in Supplies and Financial Indicators
- During the ten months of 2025, medical goods worth 4 billion soms were centrally supplied, while in 2023 this figure was only 1 billion. All supplies were made using the same working capital of 1 billion soms raised in 2023. "We continue to seek ways to improve spending efficiency and sustainable growth," noted "Kyrgyzpharm."
International Cooperation
- The enterprise receives consulting and technical assistance from organizations such as the World Bank, UNFPA, and UNICEF. This cooperation allows for the development of logistics, implementation of digitization, and application of best practices to enhance the transparency of procurement processes.
Digitization of the Procurement Process
- The platform Kyrgyzpharm.med.kg is actively used. By the end of 2025, integration with government portals is planned, which will allow tracking the movement of goods, applications, and stocks in real time.
Creation of New Jobs
- In 2026, the opening of new regional warehouses and the expansion of logistics projects are expected, which will lead to the creation of additional jobs and improvement of the drug supply infrastructure in the regions.
Quality and Control Standards
- Since the beginning of 2025, the company has implemented internal control systems, as well as KPIs at all stages—from procurement to delivery. "Kyrgyzpharm" continues to modernize its procurement system.
